⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for recurrent childhood cerebral astrocytoma

Every month we try and update this database with for recurrent childhood cerebral astrocytoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or LeukemiaNCT00053963
Blastic Phase C...
Childhood Centr...
Childhood Choro...
Childhood Chron...
Childhood Crani...
Childhood Grade...
Childhood Grade...
Childhood Grade...
Childhood High-...
Childhood Infra...
Childhood Low-g...
Childhood Spina...
Childhood Supra...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Refractory Chro...
Relapsing Chron...
Unspecified Chi...
romidepsin
- 21 YearsNational Cancer Institute (NCI)
Magnetic Resonance Imaging in Treating Children With Progressive Low-Grade AstrocytomaNCT00005084
Brain and Centr...
conventional su...
magnetic resona...
radiation thera...
- 12 YearsNational Cancer Institute (NCI)
Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain TumorsNCT00052780
Childhood Centr...
Childhood Choro...
Childhood Crani...
Childhood Epend...
Childhood Grade...
Childhood Grade...
Childhood Grade...
Childhood High-...
Childhood High-...
Childhood Infra...
Childhood Low-g...
Childhood Low-g...
Childhood Medul...
Childhood Mixed...
Childhood Oligo...
Childhood Supra...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
O6-benzylguanin...
temozolomide
filgrastim
pharmacological...
laboratory biom...
- 21 YearsNational Cancer Institute (NCI)
Carboplatin in Patients With Progressive GliomasNCT00002749
Brain and Centr...
carboplatin
- Duke University
Tumor Tissue, Blood Samples, and Family History in Predicting Tumor Development and Response to Treatment in Young Patients With Low-Grade GliomaNCT00891722
Brain and Centr...
biologic sample...
laboratory biom...
questionnaire a...
- National Cancer Institute (NCI)
Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's LymphomaNCT00006102
Brain and Centr...
Lymphoma
Neuroblastoma
Retinoblastoma
Sarcoma
Unspecified Chi...
becatecarin
- 21 YearsNational Cancer Institute (NCI)
Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain TumorsNCT00002647
Brain and Centr...
Metastatic Canc...
verteporfin
conventional su...
3 Years - 70 YearsNational Cancer Institute (NCI)
Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant GliomaNCT00008008
Brain and Centr...
filgrastim
sargramostim
cyclophosphamid...
thiotepa
autologous bone...
bone marrow abl...
peripheral bloo...
- National Cancer Institute (NCI)
Combination Chemotherapy in Treating Children With Progressive Brain TumorsNCT00002944
Brain Tumors
Central Nervous...
carboplatin
lomustine
procarbazine hy...
thioguanine
vincristine sul...
- 9 YearsChildren's Oncology Group
Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain TumorNCT00069940
Brain and Centr...
Gastrointestina...
Sarcoma
sargramostim
telomerase: 540...
2 Years - Dana-Farber Cancer Institute
Imatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent GliomaNCT00021229
Brain and Centr...
imatinib mesyla...
local irradiati...
3 Years - 21 YearsNational Cancer Institute (NCI)
Imatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent GliomaNCT00021229
Brain and Centr...
imatinib mesyla...
local irradiati...
3 Years - 21 YearsNational Cancer Institute (NCI)
Monoclonal Antibody Therapy in Treating Patients With Recurrent GliomasNCT00002753
Brain and Centr...
iodine I 131 mo...
3 Years - Duke University
18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent GliomasNCT02175745
Adult Anaplasti...
Adult Anaplasti...
Adult Brain Ste...
Adult Diffuse A...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Mixed Gli...
Adult Oligodend...
Adult Pilocytic...
Adult Pineal Gl...
Adult Subependy...
Childhood High-...
Childhood High-...
Childhood Low-g...
Childhood Low-g...
Recurrent Adult...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
18F-fluoro-dihy...
Positron emissi...
Computed tomogr...
Magnetic resona...
16 Years - Stanford University
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid TumorsNCT00002608
Adrenocortical ...
Brain and Centr...
Head and Neck C...
Liver Cancer
Malignant Mesot...
Pheochromocytom...
Sarcoma
cisplatin
doxorubicin hyd...
tamoxifen citra...
conventional su...
radiation thera...
- 65 YearsNational Cancer Institute (NCI)
O6-benzylguanine and Carmustine in Treating Children With Refractory CNS TumorsNCT00003765
Brain and Centr...
O6-benzylguanin...
carmustine
- 21 YearsNational Cancer Institute (NCI)
Lobradimil and Carboplatin in Treating Children With Brain TumorsNCT00019422
Brain and Centr...
carboplatin
lobradimil
- 21 YearsNational Cancer Institute (NCI)
High-Dose Chemotherapy Plus Autologous Stem Cell Transplantation Compared With Intermediate-Dose Chemotherapy Plus Autologous Stem Cell Transplantation With or Without Isotretinoin in Treating Young Patients With Recurrent High-Grade GliomasNCT00078988
Brain Tumor
Central Nervous...
filgrastim
carboplatin
etoposide
isotretinoin
thiotepa
autologous bone...
peripheral bloo...
- 20 YearsChildren's Oncology Group
Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain TumorsNCT00002754
Brain and Centr...
Melanoma (Skin)
Metastatic Canc...
monoclonal anti...
3 Years - Duke University
Lobradimil and Carboplatin in Treating Children With Brain TumorsNCT00019422
Brain and Centr...
carboplatin
lobradimil
- 21 YearsNational Cancer Institute (NCI)
Radiation Therapy or Combination Chemotherapy in Treating Patients With Clinically or Radiologically Progressive Low-Grade GliomasNCT00276640
Primary Central...
vincristine, ca...
vincristine, ca...
radiation thera...
1 Day - 18 YearsSociete Internationale d'Oncologie Pediatrique
VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain TumorsNCT00098761
Brain and Centr...
laromustine
- 21 YearsPediatric Brain Tumor Consortium
Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem GliomaNCT00070525
Childhood High-...
Childhood Oligo...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
tipifarnib
- 21 YearsNational Cancer Institute (NCI)
Combination Chemotherapy in Treating Children With Progressive Brain TumorsNCT00002944
Brain Tumors
Central Nervous...
carboplatin
lomustine
procarbazine hy...
thioguanine
vincristine sul...
- 9 YearsChildren's Oncology Group
Radiation Therapy or Combination Chemotherapy in Treating Patients With Clinically or Radiologically Progressive Low-Grade GliomasNCT00276640
Primary Central...
vincristine, ca...
vincristine, ca...
radiation thera...
1 Day - 18 YearsSociete Internationale d'Oncologie Pediatrique
Radiation Therapy in Treating Young Patients With GliomasNCT00238264
Brain Tumor
Central Nervous...
radiation thera...
3 Years - 20 YearsChildren's Oncology Group
Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem GliomaNCT00360854
Brain and Centr...
erlotinib hydro...
mutation analys...
polymorphism an...
laboratory biom...
pharmacological...
radiation thera...
1 Year - 21 YearsNational Cancer Institute (NCI)
Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System TumorsNCT02255461
Childhood Choro...
Childhood Epend...
Childhood Grade...
Childhood High-...
Childhood High-...
Childhood Medul...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
palbociclib ise...
pharmacological...
laboratory biom...
4 Years - 21 YearsPediatric Brain Tumor Consortium
VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain TumorsNCT00098761
Brain and Centr...
laromustine
- 21 YearsPediatric Brain Tumor Consortium
TP-38 Toxin in Treating Young Patients With Recurrent or Progressive Supratentorial High-Grade GliomaNCT00074334
Brain and Centr...
TGFa-PE38 immun...
conventional su...
3 Years - 21 YearsPediatric Brain Tumor Consortium
Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or LymphomaNCT00363272
Childhood Burki...
Childhood Centr...
Childhood Choro...
Childhood Crani...
Childhood Grade...
Childhood Grade...
Childhood Grade...
Childhood High-...
Childhood Infra...
Childhood Low-g...
Childhood Spina...
Childhood Supra...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Unspecified Chi...
ispinesib
laboratory biom...
pharmacological...
1 Year - 21 YearsNational Cancer Institute (NCI)
PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System TumorsNCT01158300
Brain and Centr...
VEGF inhibitor ...
3 Years - 21 YearsPediatric Brain Tumor Consortium
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for CancerNCT01132547
Cancer
cyproheptadine ...
placebo
2 Years - 21 YearsUniversity of South Florida
SU5416 in Treating Children With Recurrent or Progressive Brain TumorsNCT00006247
Brain and Centr...
semaxanib
- 21 YearsPediatric Brain Tumor Consortium
Cisplatin and Temozolomide in Treating Young Patients With Malignant GliomaNCT00360945
Brain and Centr...
cisplatin
temozolomide
fluorescence in...
loss of heteroz...
immunohistochem...
laboratory biom...
radiation thera...
4 Years - 20 YearsNational Cancer Institute (NCI)
Carboplatin in Patients With Progressive GliomasNCT00002749
Brain and Centr...
carboplatin
- Duke University
Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain TumorsNCT00052780
Childhood Centr...
Childhood Choro...
Childhood Crani...
Childhood Epend...
Childhood Grade...
Childhood Grade...
Childhood Grade...
Childhood High-...
Childhood High-...
Childhood Infra...
Childhood Low-g...
Childhood Low-g...
Childhood Medul...
Childhood Mixed...
Childhood Oligo...
Childhood Supra...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
O6-benzylguanin...
temozolomide
filgrastim
pharmacological...
laboratory biom...
- 21 YearsNational Cancer Institute (NCI)
Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain CancerNCT00014573
Brain and Centr...
aldesleukin
autologous tumo...
filgrastim
sargramostim
therapeutic aut...
carmustine
cisplatin
cyclophosphamid...
paclitaxel
autologous bone...
conventional su...
peripheral bloo...
- 65 YearsBarbara Ann Karmanos Cancer Institute
Cilengitide in Treating Children With Refractory Primary Brain TumorsNCT00063973
Childhood Centr...
Childhood Choro...
Childhood Crani...
Childhood Epend...
Childhood Grade...
Childhood Grade...
Childhood Grade...
Childhood High-...
Childhood High-...
Childhood Infra...
Childhood Low-g...
Childhood Low-g...
Childhood Medul...
Childhood Mixed...
Childhood Oligo...
Childhood Supra...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
cilengitide
laboratory biom...
- 21 YearsNational Cancer Institute (NCI)
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain CancersNCT00002752
Brain and Centr...
Metastatic Canc...
iodine I 131 mo...
3 Years - Duke University
Temozolomide in Treating Patients With Progressive Low-Grade GliomaNCT00003466
Brain and Centr...
temozolomide
4 Years - Duke University
Lobradimil and Carboplatin in Treating Children With Brain TumorsNCT00019422
Brain and Centr...
carboplatin
lobradimil
- 21 YearsNational Cancer Institute (NCI)
Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain TumorsNCT02194452
Acoustic Schwan...
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Brain Ste...
Adult Choroid P...
Adult Craniopha...
Adult Diffuse A...
Adult Ependymob...
Adult Ependymom...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Grade I M...
Adult Grade II ...
Adult Medullobl...
Adult Meningeal...
Adult Mixed Gli...
Adult Myxopapil...
Adult Oligodend...
Adult Papillary...
Adult Pilocytic...
Adult Pineal Gl...
Adult Pineoblas...
Adult Pineocyto...
Adult Subependy...
Adult Subependy...
Adult Supratent...
Childhood Choro...
Childhood Crani...
Childhood Epend...
Childhood Grade...
Childhood Grade...
Childhood Grade...
Childhood High-...
Childhood High-...
Childhood Infra...
Childhood Low-g...
Childhood Low-g...
Childhood Medul...
Childhood Supra...
Meningeal Melan...
Newly Diagnosed...
Recurrent Adult...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
gallium Ga 68-e...
positron emissi...
computed tomogr...
laboratory biom...
6 Months - 29 YearsUniversity of Iowa
Carmustine Implants and O(6)-Benzylguanine in Treating Children With Recurrent Malignant GliomaNCT00045721
Brain and Centr...
O6-benzylguanin...
polifeprosan 20...
adjuvant therap...
conventional su...
neoadjuvant the...
3 Years - 21 YearsPediatric Brain Tumor Consortium
FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or LeukemiaNCT00053963
Blastic Phase C...
Childhood Centr...
Childhood Choro...
Childhood Chron...
Childhood Crani...
Childhood Grade...
Childhood Grade...
Childhood Grade...
Childhood High-...
Childhood Infra...
Childhood Low-g...
Childhood Spina...
Childhood Supra...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Refractory Chro...
Relapsing Chron...
Unspecified Chi...
romidepsin
- 21 YearsNational Cancer Institute (NCI)
Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical TrialNCT00890435
Brain and Centr...
Leukemia
Unspecified Adu...
Unspecified Chi...
questionnaire a...
psychosocial as...
18 Years - Children's Oncology Group
Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard TherapyNCT00679354
Childhood High-...
Childhood High-...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
cilengitide
laboratory biom...
pharmacological...
- 21 YearsNational Cancer Institute (NCI)
Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain TumorsNCT00052780
Childhood Centr...
Childhood Choro...
Childhood Crani...
Childhood Epend...
Childhood Grade...
Childhood Grade...
Childhood Grade...
Childhood High-...
Childhood High-...
Childhood Infra...
Childhood Low-g...
Childhood Low-g...
Childhood Medul...
Childhood Mixed...
Childhood Oligo...
Childhood Supra...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
O6-benzylguanin...
temozolomide
filgrastim
pharmacological...
laboratory biom...
- 21 YearsNational Cancer Institute (NCI)
Vaccine Therapy in Treating Young Patients Who Are Undergoing Surgery for Malignant GliomaNCT00107185
Brain and Centr...
therapeutic aut...
1 Year - 18 YearsJonsson Comprehensive Cancer Center
Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain TumorNCT00069940
Brain and Centr...
Gastrointestina...
Sarcoma
sargramostim
telomerase: 540...
2 Years - Dana-Farber Cancer Institute
Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain TumorsNCT00238173
Bone Marrow Sup...
Brain and Centr...
Drug/Agent Toxi...
Long-term Effec...
filgrastim
acetylcysteine
carboplatin
cyclophosphamid...
etoposide phosp...
mannitol
sodium thiosulf...
1 Year - 18 YearsOHSU Knight Cancer Institute
Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard TherapyNCT00679354
Childhood High-...
Childhood High-...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
cilengitide
laboratory biom...
pharmacological...
- 21 YearsNational Cancer Institute (NCI)
Radiation Therapy or Combination Chemotherapy in Treating Patients With Clinically or Radiologically Progressive Low-Grade GliomasNCT00276640
Primary Central...
vincristine, ca...
vincristine, ca...
radiation thera...
1 Day - 18 YearsSociete Internationale d'Oncologie Pediatrique
Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical TrialNCT00890435
Brain and Centr...
Leukemia
Unspecified Adu...
Unspecified Chi...
questionnaire a...
psychosocial as...
18 Years - Children's Oncology Group
Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant GliomaNCT00008008
Brain and Centr...
filgrastim
sargramostim
cyclophosphamid...
thiotepa
autologous bone...
bone marrow abl...
peripheral bloo...
- National Cancer Institute (NCI)
Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System TumorsNCT02255461
Childhood Choro...
Childhood Epend...
Childhood Grade...
Childhood High-...
Childhood High-...
Childhood Medul...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
palbociclib ise...
pharmacological...
laboratory biom...
4 Years - 21 YearsPediatric Brain Tumor Consortium
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: